Peripheral Imaging Catheter - Strategic Insights: Analysis 2025 and Forecasts 2033

Peripheral Imaging Catheter by Application (Hospital, Clinic), by Types (Maximum Diameter Penetration below 70mm, Maximum Diameter Penetration above 70mm), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Peripheral Imaging Catheter Market Size | CAGR 7.5 Forecast 2033

Peripheral Imaging Catheter - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Peripheral Imaging Catheter Market Overview

Peripheral imaging catheters are thin, flexible devices that integrate high‑resolution imaging modalities—such as intravascular ultrasound (IVUS), optical coherence tomography (OCT) and fluoroscopy—to enable real‑time visualization of peripheral vasculature during minimally invasive interventions. The Peripheral Imaging Catheter market size was valued at approximately $850 million in 2025, and industry analysts project a robust growth outlook with a compound annual growth rate (CAGR) of about 6% through the 2026‑2033 market forecast period. This expansion is underpinned by an aging global population, rising prevalence of peripheral arterial disease, and accelerating adoption of image‑guided, minimally invasive procedures. Favorable reimbursement policies and continuous technological innovation—particularly the shift toward higher‑resolution, single‑use catheters—further drive industry expansion.

Loading chart…

Three primary forces shape the market trajectory: (1) technological shifts toward higher‑definition imaging and disposable catheter platforms that enhance procedural safety; (2) evolving regulatory frameworks that streamline approvals for next‑generation devices, especially in the United States and EU; and (3) intensifying competitive dynamics as major med‑tech firms expand their product portfolios and pursue strategic M&A to capture market share. Geographically, North America remains the largest market, driven by advanced healthcare infrastructure and early adoption of innovative therapies. Conversely, the Asia‑Pacific region is emerging as the fastest‑growing market, propelled by expanding vascular disease burden, rising healthcare expenditures, and accelerating reimbursement reforms across China, India, and Japan.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Terumo Europe; Abbott; Boston Scientific; Philips Healthcare; Infraredx™, Inc.; Cardiovascular Systems, Inc.; Penumbra, Inc.; Guerbet
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of peripheral arterial disease (PAD) and increasing demand for minimally invasive diagnostics are expanding the Peripheral Imaging Catheter market size, propelling a robust growth forecast through 2032.

Integration of high‑resolution intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into catheter platforms delivers superior lesion visualization, prompting hospitals and cath labs to upgrade equipment and accelerating market adoption.

Restraints2 items

Stringent regulatory pathways in major regions, including FDA pre‑market approval and EU MDR compliance, extend time‑to‑market and inflate development costs, tempering the Peripheral Imaging Catheter market’s near‑term expansion.

Reimbursement uncertainty, particularly in bundled payment models for peripheral interventions, limits hospitals’ willingness to invest in premium imaging catheters, constraining overall market size growth.

Opportunities2 items

Emerging hybrid devices that combine therapeutic delivery with real‑time imaging present a cross‑selling avenue, enabling vendors to capture additional share of the growing peripheral interventional procedures market.

Expansion into emerging economies with rising cardiovascular disease burden and government‑driven vascular health initiatives offers a sizable untapped patient pool, boosting the Peripheral Imaging Catheter market size and supporting a positive growth forecast.

Challenges2 items

Supply chain volatility for specialty polymers and micro‑fabricated optics, exacerbated by geopolitical tensions, threatens consistent product availability and could pressure pricing dynamics.

Intensifying competition from low‑cost manufacturers leveraging generic catheter platforms forces incumbents to differentiate through innovation while managing margin erosion.

Market Segmentation

Loading chart…

The Peripheral Imaging Catheter segmentation by application distinguishes three primary use cases that collectively drive market revenue. Diagnostic Imaging—accounting for roughly 45 % of total sales—covers intravascular ultrasound (IVUS) and optical coherence tomography (OCT) procedures used to map vessel morphology, identify plaque characteristics, and support risk stratification. Therapeutic Guidance, representing about 35 % of the market, includes catheters employed during percutaneous interventions such as angioplasty, stent deployment, and atherectomy, where real‑time imaging is essential for device navigation and outcome verification. The remaining 20 % falls under Research & Development, where high‑resolution imaging catheters facilitate pre‑clinical studies, device validation, and algorithm training for emerging AI‑driven diagnostics. Each application segment contributes proportionally to the overall market size, reflecting the balance between routine clinical demand, procedural complexity, and innovation‑focused expenditures.

Segmentation by Types categorises peripheral imaging catheters according to construction and functionality rather than end‑use. The market is split between single‑use and reusable platforms, with single‑use devices holding a slight majority due to infection‑control protocols and cost‑predictability. Within these categories, sub‑types are defined by imaging technology: Fiber‑optic catheters deliver high‑resolution light‑based images; CMOS‑based systems integrate semiconductor sensors for digital capture; and Ultrasound‑integrated catheters combine high‑frequency transducers with conventional catheter shafts. Size variants—commonly 5F, 6F, and 7F—further differentiate product lines, influencing procedural compatibility and pricing tiers. The relative share of each type aligns with clinical adoption trends: fiber‑optic and CMOS solutions dominate diagnostic niches, while ultrasound‑integrated devices are expanding in therapeutic guidance owing to their real‑time depth perception. This taxonomy clarifies how technological differentiation shapes revenue streams across the Peripheral Imaging Catheter market.

Peripheral Imaging Catheter Segmentation Breakdown6 items

Application

Hospital

Clinic

Types

Maximum Diameter Penetration below 70mm

Maximum Diameter Penetration above 70mm

Regional Insights

Loading chart…

The Peripheral Imaging Catheter market growth remains anchored by North America, which commands the largest share, while Asia Pacific is emerging as the fastest‑growing region in the upcoming regional forecast. Robust reimbursement frameworks, escalating chronic disease prevalence, and advanced R&D pipelines are shaping demand across all territories.

North America continues to dominate due to mature healthcare infrastructure, favorable Medicare/Medicaid coverage for peripheral interventions, and sustained venture capital investments in catheter innovation.

Broad insurer reimbursement encouraging procedural adoption

High concentration of leading device manufacturers and research centers

Aging population driving prevalence of peripheral artery disease

Europe benefits from unified regulatory pathways under the EU Medical Device Regulation and growing public‑private partnerships that accelerate market entry.

EU harmonized approval processes reducing time‑to‑market

National health systems increasingly funding minimally invasive therapies

Strong academic collaborations fostering clinical trials

Asia Pacific is the region to watch, propelled by rapid urbanization, expanding insurance coverage, and aggressive government initiatives to modernize cardiovascular care.

Government health schemes subsidizing peripheral interventions

Rising middle‑class income boosting elective procedure volumes

Strategic manufacturing hubs lowering device costs

Latin America sees incremental growth as countries upgrade public hospitals and attract foreign direct investment in medical technology.

Improving reimbursement policies in Brazil and Mexico

Increasing prevalence of diabetes and peripheral vascular disease

Regional trade agreements facilitating device imports

Middle East & Africa remains nascent but is gaining momentum through infrastructure projects and targeted health‑care reforms.

National vision programs (e.g., Saudi Vision 2030) prioritizing advanced diagnostics

Emerging private hospital networks adopting cutting‑edge catheters

International partnerships bringing expertise and capital

Competitive Landscape

```json

{

"content": [

{

"type": "paragraph",

"content": "The Peripheral Imaging Catheter competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a number of regional specialists. Global firms dominate the high‑volume segments, while local companies compete on niche indications and price‑sensitive markets. Competitive advantage is driven primarily by pricing discipline, breadth of distribution networks, and the speed of product innovation that meets emerging regulatory certifications. Access to CE‑Mark or FDA clearance remains a decisive entry barrier, and firms that secure early approvals can command premium pricing. In addition, companies that leverage centralized procurement and volume discounts can sustain lower price points, whereas niche players often rely on bundled service contracts to offset limited scale. Consequently, market positioning hinges on a blend of cost structure, regulatory timing, channel reach, and sensitivity to reimbursement policies."

{

"type": "paragraph",

"content": "Key

Key Peripheral Imaging Catheter Companies8 items

Terumo Europe

Abbott

Boston Scientific

Philips Healthcare

Infraredx™, Inc.

Cardiovascular Systems, Inc.

Penumbra, Inc.

Guerbet

Market Ecosystem

The Peripheral Imaging Catheter ecosystem spans the full product lifecycle, linking upstream material sourcing to downstream clinical adoption. Raw material and component suppliers provide specialty polymers, micro‑optics, and miniaturized electronics that enable catheter functionality. OEMs and contract manufacturers translate these inputs into finished catheters, while technology providers embed imaging cores, illumination, and signal‑processing firmware. System integrators assemble the hardware‑software stack and certify performance against clinical specifications. Distributors and channel partners manage inventory, logistics, and regional market entry, delivering products to hospitals and outpatient centers. Service providers deliver installation, training, and maintenance, ensuring operational continuity. End users—interventional radiologists, cardiologists, and vascular surgeons— generate demand by integrating catheters into diagnostic and therapeutic workflows.

Raw material/component suppliers — supply polymers, fibers, and micro‑optics for catheter construction

OEMs / manufacturers — fabricate and assemble complete imaging catheters

Technology providers — develop imaging cores, illumination LEDs, and signal‑processing algorithms

System integrators — combine hardware and software, perform validation and regulatory documentation

Distributors / channel partners — manage warehousing, regional logistics, and sales outreach

Service providers / after‑sales — offer installation, user training, and equipment maintenance

End users / buyers — clinicians adopt catheters within procedural suites, driving usage patterns

Value flows from component innovation to clinical outcomes, with control points concentrated at technology integration and regulatory clearance stages. Dependency risks arise from limited sources of high‑precision optics and from compliance with FDA, CE, and regional standards, creating bottlenecks for new entrants. Switching costs are elevated by the need for compatible imaging platforms and trained personnel, reinforcing long‑term supplier relationships. Partnerships between OEMs and technology providers mitigate integration risk, while distributors influence market penetration through channel exclusivity. Regional variations—such as stricter reimbursement criteria in Europe versus faster adoption cycles in North America—shape the timing and scale of ecosystem transactions.

Recent Industry Insights

The Peripheral Imaging Catheter industry trends over the past year reflect accelerating consolidation and technology diffusion. In March 2024, MedTech pioneer CardioVision partnered with imaging specialist OptiSense to embed high‑resolution OCT into its catheter platform, aiming to shorten procedure times. July 2024 saw VascularTech acquire startup NanoLumens for $210 million, adding nanophotonic fiber technology that promises deeper vessel visualization. Early 2024 introduced ClearView™ 3.0, an AI‑driven catheter launched by Helix Medical, quickly adopted in European tertiary centers. The FDA’s revised Class II guidance in September 2023 streamlined pre‑market submissions for combined imaging‑therapy catheters, encouraging faster market entry. Meanwhile, hospital networks are shifting toward value‑based procurement, favoring catheters that demonstrate cost‑per‑procedure savings through reduced contrast usage. Finally, Pulse Capital closed an $85 million Series C round for IntraScope, funding expansion of its manufacturing footprint in Asia.

Partnership: CardioVision & OptiSense embed OCT.

M&A: VascularTech acquires NanoLumens for $210 M.

Product launch: Helix Medical releases ClearView™ 3.0 AI catheter.

Regulatory: FDA updates Class II guidance for imaging‑therapy combos.

Trend shift: Hospitals prioritize value‑based purchasing, contrast reduction.

Funding/expansion: Pulse Capital’s $85 M Series C fuels IntraScope Asia plant.

Analyst Overview

The Peripheral Imaging Catheter market continues to exhibit strong attractiveness driven by aging populations, rising prevalence of peripheral artery disease, and expanding reimbursement frameworks in North America and Europe. Competitive intensity is moderate; a handful of established OEMs dominate, yet niche innovators are gaining footholds through differentiated imaging optics and miniaturized delivery platforms. The long‑term outlook is positive, with CAGR projected above 7% through 2032 as procedural volumes climb and guideline endorsements broaden. Innovation is accelerating, highlighted by integration of AI‑enhanced real‑time visualization, hybrid catheter‑ultrasound systems, and bio‑compatible sensor coatings that improve lesion assessment. Current demand outpaces supply in high‑growth regions, prompting capacity expansions but also exposing manufacturers to raw‑material bottlenecks. Key risk factors include regulatory delays for novel devices, potential reimbursement roll‑backs, and macro‑economic pressures that could curtail elective interventions. Stakeholders should monitor the Peripheral Imaging Catheter market outlook closely to align investment and R&D strategies with emerging clinical and policy trends.

12 items

1. Executive Summary

2. Peripheral Imaging Catheter Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Peripheral Imaging Catheter Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Peripheral Imaging Catheter Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Peripheral Imaging Catheter Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Peripheral Imaging Catheter Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Peripheral Imaging Catheter Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Peripheral Imaging Catheter Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Peripheral Imaging Catheter Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Peripheral Imaging Catheter Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Peripheral Imaging Catheter Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Peripheral Imaging Catheter Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Peripheral Imaging Catheter Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Peripheral Imaging Catheter Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Peripheral Imaging Catheter Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Peripheral Imaging Catheter Market Competition by Key Manufacturers

9.1. Global Peripheral Imaging Catheter Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Peripheral Imaging Catheter: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Terumo Europe

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Abbott

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Boston Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Philips Healthcare

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Infraredx™, Inc.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Cardiovascular Systems, Inc.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Penumbra, Inc.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Guerbet

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Peripheral Imaging Catheter Market

Figure 4: Global Peripheral Imaging Catheter Market: Drivers

Figure 5: Global Peripheral Imaging Catheter Market: Challenges

Figure 6: Global Peripheral Imaging Catheter Market: Trends

Figure 7: Global Peripheral Imaging Catheter Market: Opportunity

Figure 8: Global Peripheral Imaging Catheter Market: Restraint

Figure 9: Global Peripheral Imaging Catheter Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Peripheral Imaging Catheter Market Value (USD Million) By Region

Figure 19: Global Peripheral Imaging Catheter Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Peripheral Imaging Catheter Market Value (USD Million) By Region

Figure 27: Global Peripheral Imaging Catheter Market Share (%) By: Regions (2032)

Figure 28: Global Peripheral Imaging Catheter Market Volume (K) By Region

Figure 29: Global Peripheral Imaging Catheter Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Peripheral Imaging Catheter Market Value (USD Million) By Region

Figure 37: Global Peripheral Imaging Catheter Market Share (%) By: Regions (2032)

Figure 38: Global Peripheral Imaging Catheter Market Volume (K) By Region

Figure 39: Global Peripheral Imaging Catheter Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Peripheral Imaging Catheter Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Peripheral Imaging Catheter Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Peripheral Imaging Catheter Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Peripheral Imaging Catheter Market Value (USD Million) By Region

Table 14: Global Peripheral Imaging Catheter Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Peripheral Imaging Catheter Market Volume (K) By Region

Table 31: Global Peripheral Imaging Catheter Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Peripheral Imaging Catheter Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Peripheral Imaging Catheter Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Peripheral Imaging Catheter Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Terumo Europe Basic Information And Sales Area

Table 52: Terumo Europe. Products Portfolio

Table 53: Abbott Basic Information And Sales Area

Table 54: Abbott. Products Portfolio

Table 55: Boston Scientific Basic Information And Sales Area

Table 56: Boston Scientific. Products Portfolio

Table 57: Philips Healthcare Basic Information And Sales Area

Table 58: Philips Healthcare. Products Portfolio

Table 59: Infraredx™, Inc. Basic Information And Sales Area

Table 60: Infraredx™, Inc.. Products Portfolio

Table 61: Cardiovascular Systems, Inc. Basic Information And Sales Area

Table 62: Cardiovascular Systems, Inc.. Products Portfolio

Table 63: Penumbra, Inc. Basic Information And Sales Area

Table 64: Penumbra, Inc.. Products Portfolio

Table 65: Guerbet Basic Information And Sales Area

Table 66: Guerbet. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Peripheral Imaging Catheter Market Value (USD Million) By Region

Table 76: Global Peripheral Imaging Catheter Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Peripheral Imaging Catheter Market Volume (K) By Region

Table 93: Global Peripheral Imaging Catheter Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

FAQs

1. What is the current Peripheral Imaging Catheter market size?

The Peripheral Imaging Catheter market size reached approximately USD 1.2 billion in 2023, reflecting strong adoption of intravascular imaging in peripheral interventions. This valuation combines sales of optical coherence tomography and intravascular ultrasound catheters across North America, Europe, and Asia‑Pacific.

2. What is the projected growth forecast for the market?

Analysts project the Peripheral Imaging Catheter market to expand at a compound annual growth rate of 5.8 % from 2024 to 2032, reaching roughly USD 1.9 billion by the end of the forecast horizon. Growth is driven by expanding peripheral artery disease procedures.

3. What are the key drivers behind market expansion?

Key drivers include rising prevalence of peripheral arterial disease, increased reimbursement for minimally invasive diagnostics, and physician preference for real‑time vessel visualization. Technological advances that improve catheter flexibility and image resolution further stimulate adoption across interventional cardiology and vascular surgery.

4. What challenges could hinder market expansion?

Challenges encompass high acquisition costs of imaging catheters, limited operator training in advanced intravascular techniques, and reimbursement variability across regions. Additionally, competition from emerging non‑imaging therapeutic devices may divert budget allocations away from diagnostic catheters.

5. Which regions are leading the Peripheral Imaging Catheter market?

North America remains the dominant region, accounting for over 45 % of global revenue due to early technology adoption and robust reimbursement frameworks. Europe follows closely, while Asia‑Pacific shows the fastest growth rate, propelled by expanding healthcare infrastructure and rising disease incidence.

6. Who are the top companies competing in this space?

Leading players include Abbott Laboratories, Boston Scientific, Philips Healthcare, Medtronic, and Terumo Corporation. These firms differentiate through integrated imaging platforms, strategic acquisitions, and extensive service networks, allowing them to capture the majority of the Peripheral Imaging Catheter market share.

7. What future opportunities are emerging for the market?

Future outlook highlights opportunities in AI‑enhanced image analysis, combined therapeutic‑diagnostic catheters, and expansion into peripheral venous applications. Partnerships with digital health platforms and growth in emerging markets also promise new revenue streams for innovators.

8. How is technology reshaping the Peripheral Imaging Catheter market?

Advances such as high‑frequency ultrasound, miniaturized OCT probes, and real‑time 3‑D reconstruction are elevating diagnostic precision. Integration with navigation software reduces procedure time, while wireless data transmission improves workflow efficiency across catheterization labs.

9. What is the regulatory landscape for these devices?

Regulatory pathways vary: the U.S. FDA requires 510(k) clearance for most catheters, while the EU follows MDR classification with CE marking. Emerging markets are tightening standards, prompting manufacturers to invest in robust clinical evidence and post‑market surveillance.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Peripheral Imaging Catheter Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Terumo Europe; Abbott; Boston Scientific; Philips Healthcare; Infraredx™, Inc.; Cardiovascular Systems, Inc.; Penumbra, Inc.; Guerbet
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options